Free Trial

Stratec (ETR:SBS) Shares Up 0.2% - What's Next?

Stratec logo with Medical background

Key Points

  • Stratec SE's share price increased by 0.2% to €27.55 ($32.41) on Wednesday, after trading as high as €27.75 ($32.65).
  • The company has a market cap of $330.98 million and a price-to-earnings ratio of 33.06, indicating its valuation against earnings.
  • Stratec specializes in designing and manufacturing automation solutions for in-vitro diagnostics and life sciences, with a presence in Germany, the EU, and internationally.
  • Five stocks we like better than Stratec.

Stratec SE (ETR:SBS - Get Free Report)'s share price was up 0.2% on Wednesday . The stock traded as high as €27.75 ($32.65) and last traded at €27.55 ($32.41). Approximately 6,331 shares changed hands during mid-day trading, an increase of 1% from the average daily volume of 6,253 shares. The stock had previously closed at €27.50 ($32.35).

Stratec Stock Performance

The company has a debt-to-equity ratio of 66.97, a current ratio of 2.52 and a quick ratio of 1.65. The firm has a market cap of $330.98 million, a price-to-earnings ratio of 33.06, a price-to-earnings-growth ratio of 10.43 and a beta of 0.16. The company has a fifty day moving average price of €27.12 and a two-hundred day moving average price of €26.05.

About Stratec

(Get Free Report)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Stratec Right Now?

Before you consider Stratec, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Stratec wasn't on the list.

While Stratec currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.